Clinical Trials

Showing trials with last updates posted in 2025.

NCT01760226 | COMPLETED | EARLY_PHASE1
4 participants

Dose Adjusted EPOCH-R, to Treat Mature B Cell Malignancies

Study Type:
INTERVENTIONAL
Last Updated:
2025-10-14
Start Date:
2013-01-31
Completion:
2016-08-26
Conditions
  • Diffuse Large B Cell Lymphoma
  • Post Transplant Lymphoproliferative Disorder
  • Primary Mediastinal (Thymic) Large B-cell Lymphoma
Interventions
  • DRUG
No Results Yet
NCT00626496 | RECRUITING
3000 participants

Family Study of Lymphoproliferative Disorders

Study Type:
OBSERVATIONAL
Last Updated:
2025-10-14
Start Date:
2004-04-01
Completion:
2029-12-31
Conditions
  • Lymphoma, Non-Hodgkin
  • Leukemia, Lymphocytic, Chronic, B-Cell
  • Lymphoma, B-Cell
  • Monoclonal B-Cell Lymphocytosis
  • Multiple Myeloma
No Results Yet
NCT07215533 | RECRUITING | NA
40 participants

Effects of HIIT vs. TRE on Type 2 Diabetes Risk

Study Type:
INTERVENTIONAL
Last Updated:
2025-10-10
Start Date:
2024-03-15
Completion:
2025-09-30
Conditions
  • Obesity and Type 2 Diabetes
  • Metabolic Diseases
  • High-intensity Interval Training
  • Time-restricted Eating
Interventions
  • BEHAVIORAL
No Results Yet
NCT07215169 | RECRUITING | NA
40 participants

Manual Lymph Drainage for External Lymphedema

Study Type:
INTERVENTIONAL
Last Updated:
2025-10-10
Start Date:
2025-10-01
Completion:
2026-12-31
Conditions
  • Lymphedema of Face
  • Neoplasms
  • Radiotherapy Side Effect
  • Lymphedema Due to Radiation
Interventions
  • OTHER
No Results Yet
NCT06784193 | RECRUITING | PHASE1
180 participants

Phase 1 Study of OP-3136 in Advanced or Metastatic Solid Tumors

Study Type:
INTERVENTIONAL
Last Updated:
2025-10-10
Start Date:
2024-12-16
Completion:
2027-05-30
Conditions
  • Advanced or Metastatic ER+ HER2- Breast Cancer (mBC)
  • Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
  • Advanced or Metastatic Castration-Resistant Prostate Cancer (mCRPC)
  • Metastatic Breast Cancer
  • Fulvestrant
  • Palazestrant
Interventions
  • DRUG
No Results Yet
NCT06712810 | RECRUITING | PHASE1
46 participants

Q702 for the Treatment of Patients With Hematologic Malignancies

Study Type:
INTERVENTIONAL
Last Updated:
2025-10-10
Start Date:
2025-08-27
Completion:
2030-09-15
Conditions
  • Hematopoietic and Lymphatic System Neoplasm
  • Histiocytic Sarcoma
  • Malignant Histiocytosis
  • Peripheral T-Cell Lymphoma, Not Otherwise Specified
  • Primary Cutaneous T-Cell Non-Hodgkin Lymphoma
  • Recurrent Chronic Lymphocytic Leukemia
  • Recurrent Chronic Myelomonocytic Leukemia
  • Recurrent Follicular Lymphoma
  • Recurrent Langerhans Cell Histiocytosis
  • Recurrent Lymphoplasmacytic Lymphoma
  • Recurrent Myelodysplastic Syndrome
  • Recurrent Myelofibrosis
  • Recurrent Small Lymphocytic Lymphoma
  • Recurrent Waldenstrom Macroglobulinemia
  • Refractory Chronic Lymphocytic Leukemia
  • Refractory Chronic Myelomonocytic Leukemia
  • Refractory Erdheim-Chester Disease
  • Refractory Follicular Lymphoma
  • Refractory Langerhans Cell Histiocytosis
  • Refractory Lymphoplasmacytic Lymphoma
  • Refractory Myelodysplastic Syndrome
  • Refractory Myelofibrosis
  • Refractory Small Lymphocytic Lymphoma
  • Refractory Waldenstrom Macroglobulinemia
  • Rosai-Dorfman-Destombes Disease
  • Primary Central Nervous System Lymphoma
  • Recurrent Blastic Plasmacytoid Dendritic Cell Neoplasm
  • Recurrent Erdheim-Chester Disease
  • Recurrent Fibroblastic Reticular Cell Sarcoma
  • Recurrent Histiocytic Sarcoma
  • Recurrent Interdigitating Dendritic Cell Sarcoma
  • Recurrent Rosai-Dorfman-Destombes Disease
  • Refractory Blastic Plasmacytoid Dendritic Cell Neoplasm
  • Refractory Fibroblastic Reticular Cell Sarcoma
  • Refractory Histiocytic Sarcoma
  • Refractory Interdigitating Dendritic Cell Sarcoma
  • Refractory Rosai-Dorfman-Destombes Disease
Interventions
  • DRUG
  • PROCEDURE
  • OTHER
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page